Treatment History as a Predictor for Change in Visual Acuity After Surgical Correction of Diabetic Retinal Traction Detachment

Zachary A. Unruh, E. Ablah, Hyarettin Okut, David Chacko
{"title":"Treatment History as a Predictor for Change in Visual Acuity After Surgical Correction of Diabetic Retinal Traction Detachment","authors":"Zachary A. Unruh, E. Ablah, Hyarettin Okut, David Chacko","doi":"10.17161/kjm.vol15.16243","DOIUrl":null,"url":null,"abstract":"Introduction Tractional retinal detachment remains a leading cause of severe, persistent vision loss in those with diabetic retinopathy. The purpose of this study was to investigate factors in treatment history associated with outcomes of surgical repair for diabetic tractional retinal detachments. Methods A retrospective, cohort study design was used. Data on 64 eyes that underwent surgical correction for diabetic tractional retinal detachment were analyzed. For eyes that received any treatment within three months of surgery, the entire treatment history was recorded and analyzed. Eyes with no recorded treatment or only remote treatment outside of three months prior to surgery were considered treatment naïve. Results Of all eyes, 56% (n = 36) had received treatment for proliferative diabetic retinopathy in the three months prior to surgery. Among those treated, 50% (n = 18) of eyes had both laser and bevacizumab treatments and 44% (n = 16) had only bevacizumab injections. Average best corrected visual acuity (BCVA) for all eyes improved from 1.68 LogMAR (20/1,000) pre-operatively to 1.34 (20/400) post-operatively, p = 0.0017. Average BCVA in eyes with pre-operative treatment history improved from 1.73 (20/1,000) pre-operatively to 1.09 (20/250) post-operatively, p = 0.0006. Average BCVA in treatment-naïve eyes was 1.60 (20/800) pre-operatively and 1.66 (20/1,000) post-operatively, p = 0.638. Eyes treated only with intravitreal injections had an improvement in BCVA from 1.81 (20/1,200) pre-operatively to 0.91 (20/160) post-operatively, p = 0.006. There was no difference between tamponade agents when comparing mean change in BCVA, p = 0.944. Conclusions There was a relationship between intravitreal injection treatment history and a large improvement in BCVA, and a similar association between combined laser and injection treatment history and improvement in BCVA. These relationships, however, were not present when controlling for confounders in multivariate analysis. There were likely other factors in the patient’s treatment history such as timing, quantity, and order of treatments that played a role in the bivariate association observed in this study.","PeriodicalId":94121,"journal":{"name":"Kansas journal of medicine","volume":"15 1","pages":"123 - 126"},"PeriodicalIF":0.0000,"publicationDate":"2022-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kansas journal of medicine","FirstCategoryId":"0","ListUrlMain":"https://doi.org/10.17161/kjm.vol15.16243","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction Tractional retinal detachment remains a leading cause of severe, persistent vision loss in those with diabetic retinopathy. The purpose of this study was to investigate factors in treatment history associated with outcomes of surgical repair for diabetic tractional retinal detachments. Methods A retrospective, cohort study design was used. Data on 64 eyes that underwent surgical correction for diabetic tractional retinal detachment were analyzed. For eyes that received any treatment within three months of surgery, the entire treatment history was recorded and analyzed. Eyes with no recorded treatment or only remote treatment outside of three months prior to surgery were considered treatment naïve. Results Of all eyes, 56% (n = 36) had received treatment for proliferative diabetic retinopathy in the three months prior to surgery. Among those treated, 50% (n = 18) of eyes had both laser and bevacizumab treatments and 44% (n = 16) had only bevacizumab injections. Average best corrected visual acuity (BCVA) for all eyes improved from 1.68 LogMAR (20/1,000) pre-operatively to 1.34 (20/400) post-operatively, p = 0.0017. Average BCVA in eyes with pre-operative treatment history improved from 1.73 (20/1,000) pre-operatively to 1.09 (20/250) post-operatively, p = 0.0006. Average BCVA in treatment-naïve eyes was 1.60 (20/800) pre-operatively and 1.66 (20/1,000) post-operatively, p = 0.638. Eyes treated only with intravitreal injections had an improvement in BCVA from 1.81 (20/1,200) pre-operatively to 0.91 (20/160) post-operatively, p = 0.006. There was no difference between tamponade agents when comparing mean change in BCVA, p = 0.944. Conclusions There was a relationship between intravitreal injection treatment history and a large improvement in BCVA, and a similar association between combined laser and injection treatment history and improvement in BCVA. These relationships, however, were not present when controlling for confounders in multivariate analysis. There were likely other factors in the patient’s treatment history such as timing, quantity, and order of treatments that played a role in the bivariate association observed in this study.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
治疗史作为糖尿病视网膜牵引脱离手术矫正后视力变化的预测因素
牵引性视网膜脱离仍然是糖尿病视网膜病变患者严重、持续性视力丧失的主要原因。本研究的目的是探讨与糖尿病牵引性视网膜脱离手术修复结果相关的治疗史因素。方法采用回顾性、队列研究设计。本文分析了64只因糖尿病性牵引性视网膜脱离而行手术矫正的眼的资料。对于在手术三个月内接受任何治疗的眼睛,记录并分析整个治疗历史。手术前3个月以外未记录治疗或仅远程治疗的眼睛视为治疗naïve。结果所有眼中,56% (n = 36)在术前3个月内接受过增殖性糖尿病视网膜病变的治疗。在接受治疗的患者中,50% (n = 18)的眼睛同时接受激光和贝伐单抗治疗,44% (n = 16)的眼睛只接受贝伐单抗注射。全眼平均最佳矫正视力(BCVA)由术前的1.68 LogMAR(20/ 1000)改善至术后的1.34 (20/400),p = 0.0017。术前有治疗史的眼平均BCVA由术前1.73(20/ 1000)改善至术后1.09 (20/250),p = 0.0006。treatment-naïve眼的平均BCVA术前为1.60(20/800),术后为1.66 (20/ 1000),p = 0.638。仅玻璃体内注射治疗的眼睛BCVA从术前的1.81(20/ 1200)改善到术后的0.91 (20/160),p = 0.006。两种填塞剂在比较BCVA平均变化时差异无统计学意义,p = 0.944。结论玻璃体内注射治疗史与BCVA的显著改善之间存在相关性,激光与注射联合治疗史与BCVA的改善之间也存在类似的相关性。然而,在多变量分析中控制混杂因素时,这些关系不存在。患者的治疗史中可能还有其他因素,如治疗的时间、数量和顺序,在本研究中观察到的双变量关联中起作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Large Left Atrial Myxoma Discovered During Restaging of Breast Cancer. New and Improved Kansas Journal of Medicine: Perspective from the Editor-in-Chief. Challenges in Anesthetic Management in a 25-Year-Old Patient with Ichthyosis. Factors Affecting Parental Intent to Vaccinate Against COVID-19 in the United States. Influence of Bone Cement Augmentation on Complications in Cephalomedullary Nail Fixation of Geriatric Intertrochanteric Hip Fractures.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1